# Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

> **NCT07069738** · NA · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 850 (estimated)

## Conditions studied

- Heart Failure - NYHA II - IV

## Interventions

- **DEVICE:** CRT-D with a Quadripolar LV lead
- **DEVICE:** CRT-D with INGEVITY+ pace/sense lead

## Key facts

- **NCT ID:** NCT07069738
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-22
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069738, "Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07069738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*